Login / Signup

Rabeprazole-amoxicillin dual therapy as first-line treatment for H pylori eradication in special patients: A retrospective, real-life study.

Wen GaoHui YeXin DengChi WangYing XuYixuan LiXue-Zhi ZhangHong Cheng
Published in: Helicobacter (2020)
Dual therapy composed of rabeprazole and amoxicillin as a first-line treatment appears to be effective and safe for H pylori infection in elderly patients or those with multiple comorbidities. Additional studies are needed to optimize the regimen.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • stem cells
  • helicobacter pylori infection
  • patient reported outcomes
  • cell therapy